GL1X · GenesisL1 explorer

MolNFT v1 · #125540 · protein

Structure of the human quinone reductase 2 (NQO2) in complex with to CL097

5LBU · Ribosyldihydronicotinamide dehydrogenase [quinone]: “Structure of the human quinone reductase 2 (NQO2) in complex with to CL097”. X-ray diffraction, 4 ligands (C09, FAD, ZN), 2 pockets (best druggability 0.78). MolNFT v1 #125540 on…

PDB
5LBU
Type
protein
Length
456 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribosyldihydronicotinamide dehydrogenase [quinone]
EC
1.10.5.1
UniProt
P16083
Ligands
C09, FAD, ZN, SO4
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRibosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1)protein22842% helix, 16% strandP16083

Ligands and binding sites

  • C09 · 2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine · ligand · 4 copies · chains A, B
  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15690.780.8443C09, FAD
25490.780.8442FAD, C09

Interfaces

1 interface between chains.

  • A–B · 2042 Ų buried · 27 hydrogen bonds · protein-protein

Compared structures

  • 5LBU · Structure of the human qui reductase 2 (NQO2) in complex with to CL097 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.